Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Pfizer Inc. (PFE) had Revenue of $62.58B for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$62.58B
Net Income	$7.77B
Cost of Goods Sold	$16.07B
Gross Profit	$46.51B
Operating Expenses	$48.34B
Operating Income	$14.24B
Non-Operating Income/Expense	$-6.72B
Pre-Tax Income	$7.52B
Normalized Pre-Tax Income	$7.52B
Income after Taxes	$7.79B
Income from Continuous Operations	$7.79B
Consolidated Net Income/Loss	$7.81B
Normalized Income after Taxes	$7.79B
EBIT	$14.24B
EBITDA	$20.84B
Weighted-Average Shares Outstanding (Basic)	5.68B
Weighted-Average Shares Outstanding (Diluted)	5.71B
Earnings per Share (EPS) (Basic)	$1.37
Earnings per Share (EPS) (Diluted)	$1.36
Balance Sheet Financials
Current Assets	$42.90B
Property, Plant, and Equipment	$19.32B
Long-Term Assets	$165.26B
Total Assets	$208.16B
Current Liabilities	$36.98B
Long-Term Debt	$61.64B
Long-Term Liabilities	$84.40B
Total Liabilities	$121.39B
Common Equity	$86.78B
Tangible Shareholders Equity	$-38.22B
Shareholders Equity	$86.78B
Common Shares Outstanding	5.69B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$11.70B
Cash Flow from Investing Activities	$-1.35B
Cash Flow from Financial Activities	$-10.30B
Beginning Cash	$1.11B
End Cash	$1.20B
Increase/Decrease in Cash	$91.00M
Stock-Based Compensation	$799.00M
Common Stock Dividends Paid	$-9.77B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.16
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.42
Debt to Equity Ratio	0.75
Gross Margin	74.33%
Operating Margin	22.76%
EBIT Margin	22.76%
EBITDA Margin	33.30%
Pre-Tax Profit Margin	12.02%
Profit Margin	12.42%
Free Cash Flow	$9.07B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.30
Inventory Turnover	1.51
Receiveable Turnover	5.27
Days Sales in Receivables	69.26
Return on Equity	8.97%
Return on Tangible Equity	-20.37%
Return on Assets	3.74%
Return on Investments	5.25%
Book Value Per Share	$15.26
Free Cash Flow per Share	$1.59
Operating Cash Flow per Share	$2.05

Data from Zacks Investment Research, Inc.